Latest Ranibizumab Stories
-- Fourth indication for injection treatment that can stabilize and improve vision(1) -- mCNV a leading cause of visual impairment among those 20-50 years of age(9) Since
Fovista and Abicipar Pegol Will Need to be Priced Competitively to Current Agents to Garner Favorable Tier Placement, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Over Three-Quarters of Physicians View Ophthotech's Fovista as an Emerging Therapy with High Potential Value for Wet AMD, According to Findings from Decision Resources Group BURLINGTON, Mass.,
The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment
INCLINE VILLAGE, Nev., June 10, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
VANCOUVER, June 9, 2014 /PRNewswire/ - iCo Therapeutics Inc.
Major population study finds vasodilators may raise likelihood of age-related macular degeneration SAN FRANCISCO, May 28, 2014 /PRNewswire-USNewswire/ -- There may be a connection between taking
Roche/Genentech's Avastin Continues to Garner the Greatest Physician-Reported Patient Share in DME Due to Its Low Relative Cost, According to Findings from Decision Resources Group BURLINGTON,
LONDON, March 24, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.